Skip to content
Medical Health Aged Care

ADHD reform more urgent in NSW with psychiatrists’ workforce crisis

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs is urging the New South Wales Government to prioritise reforms to improve access to support and treatment for people with attention deficit hyperactivity disorder (ADHD) from GPs after the mass resignation of psychiatrists. 

Around 200 psychiatrists in NSW's public health system have submitted their resignations amid an ongoing pay dispute with the state government. 

RACGP New South Wales Chair Dr Rebekah Hoffman said: “GPs should be able to initiate and prescribe medications for people living with ADHD, and manage their care. Allowing GPs to give more support to people living with ADHD will improve health and wellbeing for patients, cut wait times and costs, and ease pressure on the health system. 

“The New South Wales workforce crisis makes these changes even more urgent. Psychiatrists have raised concerns over safety due to the state’s understaffed workforce. 

“We have solutions. Allowing GPs to give more support to people living with ADHD will not only help these patients, it will help ease pressure on our psychiatrist colleagues. 

“The RACGP is calling for a nationally consistent approach for ADHD prescribing that helps adults and children with ADHD access appropriate and early support from their GP, including reducing regulatory barriers for prescribing stimulant medications. 

"In NSW, GPs have to apply for approval in order to be able to prescribe stimulant medications, and they can only do it if they’re working in rural or remote communities, or if they’re practising predominantly in paediatrics.  

“People in NSW face significant barriers to ADHD care – they often have to wait months and pay hundreds of dollars for psychiatrists to confirm their diagnosis and get scripts that could be easily and safely prescribed by their GP. Now the situation is even worse. 

“I’m urging the NSW Government to work with the Federal Government to prioritise these reforms for people living with ADHD – GPs can help improve access and reduce costs for these patients, and in doing so ease pressure on our stretched health system. 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 16/01/2025
  • 05:00
GlaxoSmithKline

Local scientific discovery Omjarra (momelotinib) now TGA approved for Australians with rare bone marrow cancer

Embargoed: 06.00am Thursday 16th January 2025, MELBOURNE, AUSTRALIA Omjjara (momelotinib) was discovered by Melbourne scientists in 2005.1 Today’s TGA approval follows its recent FDA approval and makes it one of only a handful of original Australian scientific discoveries to secure both milestones.1-6 Omjjara is a once daily pill indicated to treat disease-related consequences of primary or secondary myelofibrosis including spleen enlargement and moderate to severe anaemia.7 Myelofibrosis is a rare bone marrow cancer with an average survival of 5-7 years.7-8 GSK Australia welcomes the Therapeutic Goods Administration (TGA) approval of Omjjara - a local scientific discovery now providing the first…

  • Medical Health Aged Care
  • 15/01/2025
  • 20:54
Glaxo SmithKline

Local scientific discovery Omjarra (momelotinib) TGA approved for Australians with rare bone marrow cancer

MELBOURNE PHOTO-FILMING OPPORTUNITY: THURSDAY 16TH JANUARY 2025 DATE: Thursday 16th January 2025 TIME: 10.30 – 11.30am LOCATION: 3 Torresdale Road, Toorak, Melbourne INTERVIEWEES: Prof…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.